AU2594000A - Method and means for reducing chemotherapeutic drug resistance in-situ within neoplasms of epithelial cell origin - Google Patents

Method and means for reducing chemotherapeutic drug resistance in-situ within neoplasms of epithelial cell origin

Info

Publication number
AU2594000A
AU2594000A AU25940/00A AU2594000A AU2594000A AU 2594000 A AU2594000 A AU 2594000A AU 25940/00 A AU25940/00 A AU 25940/00A AU 2594000 A AU2594000 A AU 2594000A AU 2594000 A AU2594000 A AU 2594000A
Authority
AU
Australia
Prior art keywords
neoplasms
situ
drug resistance
epithelial cell
chemotherapeutic drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25940/00A
Inventor
Olivier N. Kocher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Deaconess Medical Center Inc filed Critical Beth Israel Deaconess Medical Center Inc
Publication of AU2594000A publication Critical patent/AU2594000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU25940/00A 1998-12-31 1999-12-22 Method and means for reducing chemotherapeutic drug resistance in-situ within neoplasms of epithelial cell origin Abandoned AU2594000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22462398A 1998-12-31 1998-12-31
US09224623 1998-12-31
PCT/US1999/030876 WO2000040201A2 (en) 1998-12-31 1999-12-22 Method and means for reducing chemotherapeutic drug resistance in-situ within neoplasms of epithelial cell origin

Publications (1)

Publication Number Publication Date
AU2594000A true AU2594000A (en) 2000-07-24

Family

ID=22841463

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25940/00A Abandoned AU2594000A (en) 1998-12-31 1999-12-22 Method and means for reducing chemotherapeutic drug resistance in-situ within neoplasms of epithelial cell origin

Country Status (2)

Country Link
AU (1) AU2594000A (en)
WO (1) WO2000040201A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5072901B2 (en) * 2003-02-24 2012-11-14 譲治 稲澤 Drug resistance marker and use thereof
WO2005026328A2 (en) * 2003-09-12 2005-03-24 Uab Research Foundation Cpt resistant cell line

Also Published As

Publication number Publication date
WO2000040201A2 (en) 2000-07-13
WO2000040201A3 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU1610299A (en) Method of cancer cell detection
AU6774698A (en) System and method for cellular specimen grading
AU8510998A (en) In situ short-circuit protection system and method for high-energy electro chemical cells
AU2373200A (en) Apparatuses and methods for forming assemblies
AU2024700A (en) (in situ) method of analyzing cells
AU7063800A (en) All-solid-state electrochemical device and method of manufacturing
AU3970500A (en) An improved method and arrangement for managing cell reselection in a terminal for a cellular system
AU1461700A (en) Method and apparatus for electrochemical mechanical deposition
AU2672999A (en) Method for transparently determining and setting an optimal minimum required tcpwindow size
AU8724598A (en) System and method for automatically detecting malignant cells and cells having malignancy-associated changes
AU2937099A (en) Method and system for exploiting location-dependent services in a cellular radiosystem
AU1910000A (en) Nuclear resistance cell and methods for making same
AU6500300A (en) Assembly and method for attaching insulation material
AU6499200A (en) Pre-paid mobile telephone air-time replenishing system and method
AU5899099A (en) Porous structures and methods and apparatus for forming porous structures
AU1922500A (en) High rate electrochemical cell and assembly method
AU2324799A (en) Electrochemical battery structure and method
EP1120846A4 (en) Cell and cell inspecting method
AU5123899A (en) (in situ) method of analyzing cells
WO2000079450A8 (en) Material management system and method
AUPP278698A0 (en) Method of cell nuclei segmentation
AU5730500A (en) Method and apparatus for forming polycrystalline particles
GB9912181D0 (en) Method and electrolyte for anodizing valve materials
AU2000237154A1 (en) Method for detecting and killing epithelial cancer cells
AU5037700A (en) Separator for electrochemical cell and method of assembly

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase